Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	1.87	30.49	29.93
Graham Fair Price	57.50	76.53	48.59
PEG	-80.75	0.09	-0.47
Price/Book	5.77	1.82	1.73
Price/Cash Flow	190.24	99.82	34.39
Prices/Earnings	-56.65	13.32	30.73
Price/Sales	6.55	6.27	5.89
Price/FCF	190.24	99.82	34.39
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	76.74	0.18	0.10
Operating Margin	67.72	0.13	0.08
ROA	143.50	0.02	< 0.005
ROE	0.01	0.03	144.02
ROIC	0.01	0.02	81.44
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.16	0.27	-39.40
Dividends QOQ	-0.01	0.08	696.95
EBIT QOQ	-0.59	0.66	11.70
EPS QOQ	-0.65	1.47	125.18
FCF QOQ	0.61	-0.64	3.53
Revenue QOQ	-0.09	< 0.005	89.74
Naive Interpretation	member

03 - Financial Growth · Best

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	18.23	23.21	27.27
Days Sales Outstanding (DSO)	38.00	39.31	3.44
Inventory Turnover	4.94	3.88	-21.43
Debt/Capitalization	0.12	0.12	0.32
Quick Ratio	0.88	1.31	49.09
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	86.47	87.18	0.83
Cash	4.57	12.40	171.69
Capex	-2.34	-2.11	9.83
Free Cash Flow	4.34	1.59	-63.25
Revenue	25.35	25.37	0.09
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.27	1.23	-3.55
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.79	1.53	-14.60
Naive Interpretation	Member

06 - Financial Health · Weak

Rating